Correction to: Experimental & Molecular Medicine (2011) 43(3), 138-145; https://doi.org/10.3858/emm.2011.43.3.016; Published Online: 7 February 2011
After publication of this article, the authors noticed an error in the figure section.
The correct figures of this article should have read as below.
â–“
â–“
â–“
The authors apologize for any inconvenience caused.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Moon, MH., Jeong, JK., Seo, JS. et al. Author Correction: Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation. Exp Mol Med 50, 1–3 (2018). https://doi.org/10.1038/s12276-018-0127-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s12276-018-0127-9
